4 D Molecular Therapeutics Inc (FDMT)

Oct 14, 2025

Applying big data sentiment scoring on 4D Molecular Therapeutics Inc.Bear Alert & Daily Stock Trend Watchlist - newser.com

Oct 14, 2025

Oct 14, 2025

Will 4D Molecular Therapeutics Inc. outperform the marketMarket Performance Report & Verified Short-Term Trading Plans - newser.com

Oct 14, 2025

Oct 14, 2025

Retinitis Pigmentosa Market to Expand Significantly by 2034, States DelveInsight Report | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc - The Globe and Mail

Oct 14, 2025

Oct 14, 2025

4D Molecular Therapeutics to Participate in Chardan’s 9th Annual Genetic Medicines Conference Panel Discussions - Quiver Quantitative

Oct 14, 2025

Oct 13, 2025

Can momentum traders help lift 4D Molecular Therapeutics Inc.Quarterly Investment Review & Daily Stock Trend Reports - newser.com

Oct 13, 2025

Oct 13, 2025

4D Molecular Therapeutics, Inc. announced that it expects to receive $11 million in funding from Cystic Fibrosis Foundation - MarketScreener

Oct 13, 2025

Oct 13, 2025

4D Molecular Therapeutics Receiving $11 Million in Funding for Cystic Fibrosis Study - MarketScreener

Oct 13, 2025

Oct 13, 2025

Published on: 2025-10-13 08:38:02 - newser.com

Oct 13, 2025

Oct 13, 2025

How institutional ownership impacts 4D Molecular Therapeutics Inc. stockTrade Ideas & Precise Buy Zone Tips - newser.com

Oct 13, 2025

Oct 13, 2025

Is it too late to sell 4D Molecular Therapeutics Inc.Market Rally & Weekly Breakout Opportunity Watchlist - newser.com

Oct 13, 2025

Oct 13, 2025

4D Molecular (FDMT) Gains $11M Support for Cystic Fibrosis Treat - GuruFocus

Oct 13, 2025

Oct 13, 2025

Is it time to cut losses on 4D Molecular Therapeutics Inc.Trade Signal Summary & Risk Managed Investment Strategies - newser.com

Oct 13, 2025

Oct 13, 2025

4D Molecular Therapeutics, Inc. Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation - MarketScreener

Oct 13, 2025

Oct 10, 2025

When is the best time to exit 4D Molecular Therapeutics Inc.Rate Hike & Risk Managed Investment Entry Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Momentum divergence signals in 4D Molecular Therapeutics Inc. chart2025 Top Decliners & Short-Term Swing Trade Alerts - newser.com

Oct 10, 2025

Oct 09, 2025

Will 4D Molecular Therapeutics Inc. see short term momentumJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com

Oct 09, 2025

Oct 08, 2025

4D Molecular Therapeutics Inc Stock Analysis and ForecastGlobal Market Influence & Access Powerful Market Insights - earlytimes.in

Oct 08, 2025

Oct 06, 2025

Real time alert setup for 4D Molecular Therapeutics Inc. performancePortfolio Value Summary & AI Based Buy/Sell Signal Reports - newser.com

Oct 06, 2025

Oct 05, 2025

What drives 4D Molecular Therapeutics Inc stock priceTrade Execution Strategies & Free Stock Chart Pattern Guides - earlytimes.in

Oct 05, 2025

Oct 05, 2025

Statistical indicators supporting 4D Molecular Therapeutics Inc.’s strength2025 Valuation Update & Weekly High Return Opportunities - newser.com

Oct 05, 2025

Oct 03, 2025

4D Molecular Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:FDMT - Benzinga

Oct 03, 2025

Oct 03, 2025

4D Molecular Therapeutics Appoints New Financial Officer - MSN

Oct 03, 2025

Oct 03, 2025

Is 4D Molecular Therapeutics (NASDAQ:FDMT) In A Good Position To Invest In Growth? - Yahoo Finance

Oct 03, 2025

Oct 03, 2025

How 4D Molecular Therapeutics Inc. stock responds to policy changesJuly 2025 Outlook & Technical Pattern Based Buy Signals - newser.com

Oct 03, 2025

Oct 03, 2025

What MACD signals say about 4D Molecular Therapeutics Inc.2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com

Oct 03, 2025

Oct 02, 2025

What the charts say about 4D Molecular Therapeutics Inc. todayProduct Launch & Accurate Buy Signal Alerts - newser.com

Oct 02, 2025

Oct 02, 2025

4D Molecular Therapeutics says on Sept 30, appointed Ashoo Gupta as principal financial officerSEC filing - MarketScreener

Oct 02, 2025

Sep 30, 2025

4D Molecular Therapeutics: This Gene Therapy Company May Soon Surprise Investors (NASDAQ:FDMT) - Seeking Alpha

Sep 30, 2025

Sep 28, 2025

What analysts say about 4D Molecular Therapeutics Inc stockMarket Insider Reports & Free Explosive Wealth Accumulation - earlytimes.in

Sep 28, 2025

Sep 27, 2025

Is 4D Molecular Therapeutics Inc. stock reversal real or fakeWeekly Stock Summary & Consistent Growth Equity Picks - newser.com

Sep 27, 2025

Sep 27, 2025

News impact scoring models applied to 4D Molecular Therapeutics Inc.July 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com

Sep 27, 2025

Sep 27, 2025

Bizily Scott sells 4D Molecular Therapeutics (FDMT) stock worth $19,256 By Investing.com - Investing.com Canada

Sep 27, 2025

Sep 26, 2025

Bizily Scott sells 4D Molecular Therapeutics (FDMT) stock worth $19,256 - Investing.com India

Sep 26, 2025

Sep 26, 2025

4D Molecular Therapeutics Inc. stock daily chart insightsWeekly Trend Report & Verified Technical Trade Signals - newser.com

Sep 26, 2025

Sep 22, 2025

Is 4D Molecular Therapeutics Inc. stock bottoming outStop Loss & Accurate Entry/Exit Alerts - newser.com

Sep 22, 2025

Sep 22, 2025

Custom strategy builders for tracking 4D Molecular Therapeutics Inc.2025 Price Momentum & AI Forecasted Entry and Exit Points - newser.com

Sep 22, 2025